Skip to main content
Clinical Trials/NCT04924985
NCT04924985CompletedNot Applicable

Goal-Directed Cardiopulmonary Resuscitation in Cardiac Arrest Using a Novel Physiological Target

NYU Langone Health2 sites in 1 country106 target enrollmentStarted: February 11, 2022Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
106
Locations
2
Primary Endpoint
Rate of Return of Spontaneous Circulation (ROSC)

Study Overview

Brief Summary

The proposed study is a single-center, randomized controlled pilot trial of adults who suffer in-hospital cardiac arrests. Using cerebral oxygenation and end-tidal carbon dioxide physiological targets to predict survival and neurological outcome, the impact of physiological-feedback CPR will be assessed. 150 adult patients who have a cardiac arrest event at NYU Tisch Hospital will be randomized to one of two treatment groups: (1) Physiological-Feedback CPR or (2) Non-Physiological (Audiovisual) Feedback CPR.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • In-hospital cardiac arrest patient
  • Age ≥18 years
  • Age <80 years
  • CPR lasting ≥5 minutes

Exclusion Criteria

  • Patients < 18 years of age or > 80 years of age
  • Out of hospital cardiac arrest patients
  • ≥3 acute organ failures (defined as acute renal failure requiring dialysis, fulminant liver failure i.e. liver failure with INR≥1.5, respiratory failure requiring mechanical ventilation)
  • Repeat in-hospital cardiac arrest event within 14 days of a prior cardiac arrest
  • Presence of known raised intracranial pressure
  • Presence of known traumatic brain injury or subarachnoid hemorrhage <14 days old, frontal lobe brain tumors or subdural hemorrhage
  • Hyperbilirubinemia >1.0 mg/dl (based on the absorption of near-infrared light by bilirubin)
  • Resuscitation using extra-corporeal membrane oxygenation (ECMO)

Arms & Interventions

Non-Physiological (Audiovisual) Feedback CPR

Active Comparator

Intervention: Non-Physiological Feedback CPR (Other)

Physiological Feedback CPR

Experimental

Intervention: Physiological Feedback CPR (Other)

Outcomes

Primary Outcomes

Rate of Return of Spontaneous Circulation (ROSC)

Time Frame: Day 0

Secondary Outcomes

  • Release of Lactate(Day 0)
  • Release of interleukin (IL)-6(Day 0)
  • Cerebral Performance Category (CPC) Score(Day 30)
  • Change in mean rSO2 during CPR as markers of the quality of resuscitation(Day 0)
  • Change in mean ETCO2 during CPR as markers of the quality of resuscitation(Day 0)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials